Latest Safety News

Page 18 of 252
Prescient Therapeutics has given shareholders another week to participate in its A$7 million share purchase plan, citing delayed documentation and requests for more time. The capital raising is intended to fund PTX-100 through a planned December 2026 Dose Optimisation Committee meeting.
Ada Torres
Ada Torres
8 Sept 2026
Black Cat Syndicate has appointed mining veteran Chris Stone as Acting Managing Director, with the interim arrangement beginning immediately and running indefinitely. Stone will earn $600,000 a year plus superannuation while the company searches for a permanent appointment.
Maxwell Dee
Maxwell Dee
8 Sept 2026
Elevra Lithium is positioning its Québec operations for a near-doubling in spodumene concentrate capacity, while guiding to modest production growth and sharply higher capital spending in FY27. The three-stage North American Lithium expansion is targeting 373,000 tonnes per year for an estimated US$271 million.
Maxwell Dee
Maxwell Dee
8 Sept 2026
Emyria has reported a sharp increase in FY26 revenue while expanding its psychedelic-assisted therapy network to five operational or announced clinics and 18 beds. Its first Sydney clinic is now fitted out and scheduled to begin treating patients in September, but utilisation and funding remain the next tests.
Ada Torres
Ada Torres
8 Sept 2026
Clever Culture Systems secures a follow-up order from Novo Nordisk for two APAS Independence instruments, marking a critical step toward broader global deployment and signalling expected sales growth from FY27.
Ada Torres
Ada Torres
7 Sept 2026
Port of Tauranga has gained fast-track approval for its Stella Passage development, a key infrastructure project aimed at boosting freight capacity and supply chain efficiency in New Zealand.
Victor Sage
Victor Sage
7 Sept 2026
Arovella Therapeutics has released the first clinical batch of its off-the-shelf cell therapy ALA-101 and activated its inaugural trial site at The Alfred, setting the stage for patient dosing later this month.
Ada Torres
Ada Torres
7 Sept 2026
Phoslock Environmental Technologies has advanced a new range of lanthanum-enhanced phosphorus-binding products showing up to four times the capacity of current offerings, with pilot and manufacturing tests confirming strong performance and low lanthanum release. Field trials are underway, aiming for commercial sales in 2027.
Maxwell Dee
Maxwell Dee
7 Sept 2026
Thrive Tribe Technologies (ASX:1TT) has landed a three-year exclusive distribution agreement with Canadian NATO-registered defence contractor Effective Acceleration Ventures (EAV) to roll out its WooBoard and REFFIND platforms across NATO military forces.
Sophie Babbage
Sophie Babbage
7 Sept 2026
Actinogen Medical (ASX:ACW) has clarified that no undisclosed information explains recent unusual trading in its shares, pointing instead to recent underwriting of options and published updates. The biotech also reaffirmed compliance with ASX rules and provided a detailed update on its lead Alzheimer’s drug Xanamem and ongoing clinical trials.
Ada Torres
Ada Torres
4 Sept 2026
Star Minerals has transitioned from explorer to producer with mining underway at its Tumblegum South Gold Project and anticipates first gold revenue in the December quarter of 2026.
Maxwell Dee
Maxwell Dee
4 Sept 2026
Immuron Limited has inked an exclusive US distribution deal for PROIBS®, a European-certified medical device targeting abdominal discomfort, marking a key step in its digestive health portfolio growth.
Ada Torres
Ada Torres
4 Sept 2026

Browse the archive

Full archive